17,881 resources
By Version
By Realm
Start Prev Rows 12200 - 12400 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
hl7.fhir.us.directory-query | R4 | SpecialtyAndDegreeLicenseCertificateVS | Specialties, Degrees, Licenses, and Certificates Value Set | active | 2022-12 | us | fhir tho | ||
hl7.fhir.us.davinci-pdex-plan-net | R4 | SpecialtyAndDegreeLicenseCertificateVS | Specialties, Degrees, Licenses, and Certificates VS | trial-use | fm | 2025-02 | us | fhir tho | |
hl7.fhir.us.ndh | R4 | SpecialtyAndDegreeLicenseCertificateVS | Specialties, Degrees, Licenses, and Certificates Value Set | trial-use | pa | 2025-07 | us | vsac tho | |
hl7.fhir.us.directory-query | R4 | SpecialtiesVS | Specialties Value Set | active | 2022-12 | us | fhir | ||
hl7.fhir.us.davinci-pdex-plan-net | R4 | SpecialtiesVS | Specialties VS | trial-use | fm | 2025-02 | us | fhir nucc | |
hl7.fhir.uv.sdc | R4 | species | Questionnaire Context Species | informative | fhir | 2025-08 | uv | sct | |
hl7.fhir.us.registry-protocols | R4 | VentricularSupportDeviceType | Ventricular Support Device Type | active | cic | 2023-11 | us | fhir sct | |
hl7.fhir.fr.core | R4 | fr-core-vs-availability-time-rule | Recurrent caracteristic of the Schedule | Caractère récurrent du Schedule | informative | 1 | fhir | 2024-09 | fr | |
hl7.terminology | R5 | v3-Sequencing | Sequencing | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ResearchSubjectRoleBasis | ResearchSubjectRoleBasis | active | 2014-03 | uv | tho | ||
hl7.fhir.fr.core | R4 | fr-core-vs-availability-time-day | First day of the workweek | Premier jour de la semaine de travail | informative | 1 | fhir | 2024-09 | fr | fhir |
hl7.terminology | R5 | v3-ResponseMode | ResponseMode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ProvenanceEventCurrentState-DC | ProvenanceEventCurrentState-DC | active | 2014-08 | uv | tho | ||
hl7.terminology | R5 | v3-ProvenanceEventCurrentState | ProvenanceEventCurrentState | active | 2014-08 | uv | tho | ||
hl7.terminology | R5 | v3-ProvenanceEventCurrentState-AS | ProvenanceEventCurrentState-AS | active | 2014-08 | uv | tho | ||
hl7.eu.fhir.idea4rc | R4 | larynx-subsite-athena-i4rc | Larynx subsite: Athena | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | larynx-subsite-sct-i4rc | Larynx subsite: Snomed CT | active | 2025-07 | eu | sct | ||
hl7.eu.fhir.idea4rc | R4 | oropharynx-subsite-athena-i4rc | Oropharynx subsite: Athena | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | oropharynx-subsite-sct-i4rc | Oropharynx subsite: Snomed CT | active | 2025-07 | eu | sct | ||
hl7.eu.fhir.idea4rc | R4 | upperLower-limbs-subsite-athena-i4rc | Upper and Lower limbs subsite: Athena | active | 2025-07 | eu | internal | ||
hl7.eu.fhir.idea4rc | R4 | hypopharynx-subsite-athena-i4rc | Hypopharynx subsite: Athena | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | hypopharynx-subsite-sct-i4rc | Hypopharynx subsite: Snomed CT | active | 2025-07 | eu | sct | ||
hl7.eu.fhir.idea4rc | R4 | lip-subsite-athena-i4rc | Lip subsite: Athena | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | lip-subsite-sct-i4rc | Lip subsite: Snomed CT | active | 2025-07 | eu | sct | ||
hl7.eu.fhir.idea4rc | R4 | nasal-paranasal-subsite-athena-i4rc | Nasal cavity and paranasal sinuses subsite: Athena | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | nasal-paranasal-subsite-sct-i4rc | Nasal cavity and paranasal sinuses subsite: Snomed CT | active | 2025-07 | eu | sct | ||
hl7.eu.fhir.idea4rc | R4 | nasopharynx-subsite-athena-i4rc | Nasopharynx subsite: Athena | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | nasopharynx-subsite-sct-i4rc | Nasopharynx subsite: Snomed CT | active | 2025-07 | eu | sct | ||
hl7.eu.fhir.idea4rc | R4 | oralCavity-subsite-athena-i4rc | Oral cavity subsite: Athena | active | 2025-07 | eu | internal | ||
hl7.eu.fhir.idea4rc | R4 | oralCavity-subsite-sct-i4rc | Oral cavity subsite: Snomed CT | active | 2025-07 | eu | sct | ||
hl7.eu.fhir.idea4rc | R4 | genito-urinary-subsite-athena-i4rc | Genito urinary subsite: Athena | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | intra-abdominal-subsite-athena-i4rc | Intra abdominal subsite: Athena | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | intra-thoracic-subsite-athena-i4rc | Intra thoracic subsite : Athena | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | trunk-wall-subsite-athena-i4rc | Trunk wall subsite: Athena | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | nasal-subsite-athena-i4rc | Subsites: Athena | draft | 2025-07 | eu | internal | ||
hl7.eu.fhir.idea4rc | R4 | nasal-subsite-sct-i4rc | Subsites: SNOMED CT | active | 2025-07 | eu | sct | ||
hl7.terminology | R5 | v3-ActRelationshipConditional | ActRelationshipConditional | active | 2014-03 | uv | tho | ||
hl7.fhir.uv.tools | R5 | id-expectation | Id Expectation Set | informative | 4 | fhir | 2025-08 | uv | fhir |
hl7.terminology | R5 | v3-ResponseLevel | ResponseLevel | active | 2014-03 | uv | tho | ||
hl7.fhir.uv.extensions | R5 | specimen-reject-reason | Specimen Reject Reason Codes | draft | oo | 2023-01 | uv | tho | |
ca.on.oh-olis | R4 | olis-SpecimenSourceCodes | SpecimenSourceCodes | active | |||||
hl7.fhir.us.mcode | R4 | mcode-human-specimen-type-vs | Human Specimen Type Value Set | active | 1 | cic | 2025-02 | us | tho |
Hl7PlBaseIg | R5 | pl-organization-cell-type | Organization Cell Type (PL) | draft | 2025-08 | ||||
Hl7PlBaseIg | R5 | pl-practitioner-specialty | Practitioner specialty (PL) | draft | 2025-08 | ||||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.7--20200901000000 | SpierspanningCodelijst | active | nl | oid | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.7--20171231000000 | SpierspanningCodelijst | active | nl | oid | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.3--20200901000000 | SpierspanningScoreCodelijst | active | nl | loinc | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.3--20171231000000 | SpierspanningScoreCodelijst | active | nl | loinc | |||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-guideline-stage-classification | Guideline Stage Classification | draft | 2022-09 | uv | internal | ||
hl7.fhir.us.mcode | R4 | mcode-clin-or-path-modifier-vs | Clinical or Pathologic Modifier | active | cic | 2025-02 | us | sct | |
hl7.fhir.us.mcode | R4 | mcode-lymphoma-stage-value-vs | Lymphoma Stage Value Set | active | cic | 2025-02 | us | ncit sct | |
hl7.fhir.us.mcode | R4 | mcode-lymphoma-staging-method-vs | Lymphoma Staging System Value Set | active | cic | 2025-02 | us | ncit sct | |
hl7.fhir.us.mcode | R4 | mcode-tnm-staging-method-vs | TNM Staging Method Value Set | active | cic | 2025-02 | us | ncit sct | |
hl7.fhir.us.mcode | R4 | mcode-figo-staging-method-vs | FIGO Staging Method Value Set | active | cic | 2025-02 | us | sct | |
hl7.fhir.us.mcode | R4 | mcode-lymphoma-stage-value-modifier-vs | Lymphoma Stage Value Modifier Value Set | active | cic | 2025-02 | us | sct | |
hl7.fhir.us.mcode | R4 | mcode-cancer-staging-method-vs | Cancer Staging Method Value Set | active | 4 | cic | 2025-02 | us | ncit sct |
hl7.fhir.us.breastcancer | R3 | oncology-StainingIntensityVS | BC StainingIntensityVS ValueSet | draft | 2018-08 | us | sct | ||
hl7.fhir.au.ereq | R4 | ranzcr-radiology-referral | RANZCR Radiology Referral | draft | 0 | 2025-02 | au | sct | |
hl7.fhir.uv.extensions | R5 | questionnaire-item-control | Questionnaire Item UI Control Codes Value Set | trial-use | 3 | fhir | 2025-08 | uv | fhir |
hl7.terminology | R5 | reaction-event-certainty | AllergyIntoleranceCertainty | draft | pc | 2020-02 | uv | tho | |
hl7.eu.fhir.idea4rc | R4 | status-last-followup-i4rc | Status at the Last Follow Up | active | 2025-07 | eu | internal | ||
fhir.outburn.co.il | R4 | vs-condition-clinical-status | Condition Clinical Status | draft | us | tho | |||
hl7.terminology | R5 | v2-0323 | hl7VS-actionCode | active | 2019-12 | uv | tho | ||
hl7.terminology | R5 | v2-0339 | hl7VS-advancedBeneficiaryNoticeCode | active | 2019-12 | uv | tho | ||
hl7.terminology | R5 | v2-0322 | hl7VS-completionStatus | active | 2019-12 | uv | tho | ||
hl7.fhir.sami.core | R4 | Condition_status | Status da Condição | active | 2022-02 | sami | |||
hl7.fhir.sami.core | R4 | Procedure_status | Status do Procedimento | active | 2022-03 | sami | |||
hl7.terminology | R5 | v3-xDocumentStatus | x_DocumentStatus | active | 2014-03 | uv | tho | ||
NHSDigital.FHIR.STU3 | R3 | ValueSet-eRS-ClinicalInformationStatus-1 | eRS Clinical Information Status | active | 2021-03 | ||||
ca.on.ppr.r4 | R4 | ProviderRoleStatusType-provider | ProviderRoleStatusType | draft | |||||
hl7.terminology | R5 | verificationresult-validation-status | Validation-status | active | pa | 2024-04 | uv | tho | |
hl7.eu.fhir.pcsp | R4 | vs-sct-donorType-eu-pcsp | Stem Cell Donor type | draft | 2025-08 | eu | internal | ||
hl7.eu.fhir.pcsp | R4 | vs-sct-sourceType-eu-pcsp | Stem Cell Source type | draft | 2025-08 | eu | internal | ||
hl7.eu.fhir.pcsp | R4 | vs-sct-type-eu-pcsp | Stem Cell Transplantation type | draft | 2025-08 | eu | sct | ||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.2.3--20171231000000 | StomaLateraliteitCodelijst | active | nl | sct | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.2.1--20200901000000 | StomaTypeCodelijst | active | nl | sct tho | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.2.1--20171231000000 | StomaTypeCodelijst | active | nl | fhir sct | |||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | ceosys-vs-recommendation-strength | Recommendation Strength | draft | 2022-09 | uv | internal | ||
hl7.fhir.us.registry-protocols | R4 | StressTestResults | Stress Test Results | active | cic | 2023-11 | us | fhir | |
hl7.fhir.us.registry-protocols | R4 | StressTestRiskExtentofIschemia | Stress Test Risk/Extent of Ischemia | active | cic | 2023-11 | us | fhir | |
hl7.terminology | R5 | definition-use | Structure Definition Use Codes / Keywords | active | 2020-02 | uv | tho | ||
hl7.fhir.uv.extensions.r3 | R3 | definition-use | Structure Definition Use Codes / Keywords | normative | 5 | fhir | uv | tho | |
hl7.terminology | R5 | v3-SubarachnoidRoute | SubarachnoidRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-SubconjunctivalRoute | SubconjunctivalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-SubcutaneousRoute | SubcutaneousRoute | active | 2014-03 | uv | tho | ||
hl7.fhir.dk.core | R4 | dk-core-RegionalSubDivisionCodes | DK Regional Subdivision Codes | active | 2025-02 | dk | internal | ||
openehr.base | R5 | subject-relationship | Subject Relationship | informative | 3 | fhir | 2024-08 | uv | |
hl7.fhir.nl.zorgviewer | R3 | SubjectRoleCodelist | Subject rol (beroepen) waardelijst | active | 2025-08 | nl | sct | ||
hl7.terminology | R5 | v3-SublesionalRoute | SublesionalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-SublingualRoute | SublingualRoute | active | 2014-03 | uv | tho | ||
hl7.fhir.us.registry-protocols | R4 | SubmissionType | Submission Type | active | cic | 2023-11 | us | fhir | |
ca.ab.fhir.psab | R4 | submission-metadata | SubmissionMetadata | draft | 2024-06 | ca | |||
ch.fhir.ig.ch-term | R4 | SubmissionSet.Author.AuthorRole | SubmissionSet.Author.AuthorRole | active | 2025-05 | ch | oid | ||
ch.fhir.ig.ch-epr-term | R4 | SubmissionSet.Author.AuthorRole | SubmissionSet.Author.AuthorRole | active | 2023-12 | ch | oid | ||
ch.fhir.ig.ch-term | R4 | SubmissionSet.contentTypeCode | SubmissionSet.contentTypeCode | active | 2025-05 | ch | sct | ||
ch.fhir.ig.ch-epr-term | R4 | SubmissionSet.contentTypeCode | SubmissionSet.contentTypeCode | active | 2023-12 | ch | sct | ||
hl7.terminology | R5 | v3-SubmucosalRoute | SubmucosalRoute | active | 2014-03 | uv | tho | ||
hl7.fhir.uv.aitransparency | R4 | ProvenanceVS | Recommended provenance codes | draft | 0 | ehr | 2025-08 | uv | fhir tho |
hl7.terminology | R5 | fhir-clinical-doc-information-recipient | FHIR Clinical Document Information Recipients Participant Types | active | sd | 2025-04 | uv | tho | |
hl7.fhir.us.pacio-pfe | R4 | pfe-us-core-category-vs | Personal Functioning and Engagement US Core Value Set | trial-use | 3 | pc | 2025-07 | us | fhir |
uk.nhsdigital.r4.test | R4 | UKCore-England-organisation-type | NHSMIMOrganisationType | draft | |||||
hl7.terminology | R5 | substance-category | Substance Category Codes | active | 2 | oo | 2024-04 | uv | tho |
hl7.fhir.us.pq-cmc-fda | R5 | substance-classification | Substance Classification | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.uv.emedicinal-product-info | R5 | substance | Substances | active | 2025-07 | uv | |||
hl7.terminology | R5 | v3-SubstanceAdminGenericSubstitution | SubstanceAdminGenericSubstitution | active | 2014-03 | uv | tho | ||
hl7.fhir.ee.mpi | R5 | person-relationship | Person Relationship | draft | 2023-12 | ee | sct | ||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-rating-benefit-and-harms | Rating Benefit And Harms | draft | 2022-09 | uv | internal | ||
hl7.terminology | R5 | v3-SupernumeraryTooth | SupernumeraryTooth | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | measure-supplemental-data | Measure Supplemental Data | active | cqi | 2023-02 | uv | tho | |
hl7.terminology | R5 | v3-ActClassSupply | ActClassSupply | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-SupplyDetectedIssueCode | SupplyDetectedIssueCode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-GeneralPurposeOfUse | GeneralPurposeOfUse | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-PurposeOfUse | PurposeOfUse | active | 2024-02 | uv | tho | ||
hl7.terminology | R5 | v3-SuppositoryRoute | SuppositoryRoute | active | 2014-03 | uv | tho | ||
hl7.fhir.us.registry-protocols | R4 | SurgicalRisk | SurgicalRisk | active | cic | 2023-11 | us | fhir | |
hl7.eu.fhir.idea4rc | R4 | surgery-complication-eu-i4rc | Surgery Complication | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | surgery-intention-eu-i4rc | Surgery Intention | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | surgery-outcome-eu-i4rc | Surgery Outcome | active | 2025-07 | eu | |||
hl7.eu.fhir.pcsp | R4 | vs-action-eu-pcsp | Surgical Actions | draft | 2025-08 | eu | internal sct | ||
hl7.fhir.us.ccda | R4 | 2.16.840.1.113883.11.20.1.1 | SurgicalOperationNoteDocumentTypeCode | trial-use | cgp | 2018-05 | us | loinc | |
hl7.terminology | R5 | v3-Swish | Swish | active | 2014-03 | uv | tho | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.5--20200901000000 | SymptoomCodelijst | active | nl | sct tho | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.5--20171231000000 | SymptoomCodelijst | active | nl | fhir sct | |||
hl7.fhir.us.registry-protocols | R4 | SyntaxScore | Syntax Score for the PCI procedure | active | cic | 2023-11 | us | fhir | |
hl7.fhir.us.vrdr | R4 | vrdr-system-reject-vs | System Reject ValueSet | active | pher | 2024-10 | us | fhir | |
hl7.fhir.eu.base-r5 | R5 | oid-ehicPersonalId | EHIC Personal ID (system IDs - oid) | draft | 2025-08 | eu | ietf | ||
hl7.fhir.eu.base | R4 | oid-ehicPersonalId | EHIC Personal ID (system IDs - oid) | draft | 2025-08 | eu | ietf | ||
hl7.fhir.eu.base-r5 | R5 | uri-ehicPersonalId | EHIC Personal ID (system IDs - uri) | draft | 2025-08 | eu | ietf | ||
hl7.fhir.eu.base | R4 | uri-ehicPersonalId | EHIC Personal ID (system IDs - uri) | draft | 2025-08 | eu | ietf | ||
us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.193 | Conditions Associated with Head and Neck Radiotherapy | active | 2017-03 | us | icd | ||
hl7.eu.fhir.pcsp | R4 | mcode-cancer-staging-system-vs | Cancer Staging System Value Set | draft | 2025-08 | eu | sct | ||
fhir.outburn.co.il | R4 | vs-loinc-tbd | TBD LOINC Codes | draft | us | ||||
hl7.fhir.us.registry-protocols | R4 | TIMIFlow | TIMI Flow | active | cic | 2023-11 | us | sct | |
fhir.r4.nhsengland.programme | R4 | England-TaskCode | England Task Code | draft | 2024-10 | us | fhir sct | ||
fhir.r4.nhsengland.programme | R4 | England-JobRoleCode | England Job Role Code | draft | 2024-10 | us | tho | ||
hl7.terminology | R5 | adverse-event-causality-method | AdverseEventCausalityMethod | active | 1 | pc | 2024-04 | uv | tho |
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.2.2--20200901000000 | TabakGebruikStatusCodelijst | active | nl | sct tho | |||
de.fhir.medication | R4 | TimingWhenDgMP | Timing When dgMP | draft | 2025-07 | fhir | |||
hl7.terminology | R5 | subscription-tag | SubscriptionTag | draft | fhir | 2020-02 | uv | tho | |
hl7.fhir.us.pco | R4 | prom-target-measures | PROM Target Measure Scores | draft | 2 | pc | 2025-08 | us | loinc |
hl7.terminology | R5 | v3-ParticipationBeneficiary | ParticipationBeneficiary | active | 2014-03 | uv | tho | ||
ca.on.oh-olis | R4 | olis-NatureOfAbnormalTest | NatureOfAbnormalTest | active | tho | ||||
hl7.terminology | R5 | v3-ParticipationIndirectTarget | ParticipationIndirectTarget | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParticipationTargetDirect | ParticipationTargetDirect | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParticipationConsumable | ParticipationConsumable | active | 2014-03 | uv | tho | ||
hl7.fhir.au.ereq | R4 | au-erequesting-task-businessstatus | AU eRequesting Task Business Status | draft | 0 | 2025-05 | au | tho | |
hl7.fhir.au.ereq | R4 | au-erequesting-task-status | AU eRequesting Task Status | draft | 0 | 2024-09 | au | fhir | |
hl7.fhir.au.ereq | R4 | au-erequesting-fulfilment-task-tags | AU eRequesting Fulfilment Task Tags | draft | 0 | 2025-01 | au | tho | |
hl7.fhir.uv.phenomics-exchange | R4 | Taxonomy | Taxonomy | draft | cic | 2020-02 | uv | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.11.2--20200901000000 | TeKledenLichaamsdeelCodelijst | active | nl | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.11.2--20171231000000 | TeKledenLichaamsdeelCodelijst | active | nl | sct | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.10.2--20200901000000 | TeWassenLichaamsdeelCodelijst | active | nl | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.10.2--20171231000000 | TeWassenLichaamsdeelCodelijst | active | nl | sct | |||
hl7.terminology | R5 | v3-ObservationInterpretationExceptions | ObservationInterpretationExceptions | active | 2014-03 | uv | tho | ||
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-radiotherapy-free-breathing-motion-mgmt-technique-vs | Radiotherapy Free-Breathing Motion Management Technique Value Set | active | cgp | 2025-02 | us | sct | |
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.2.2--20200901000000 | TekstStatusCodelijst | active | nl | oid | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.2.2--20171231000000 | TekstStatusCodelijst | active | nl | oid | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.2.1--20200901000000 | TekstUitslagTypeCodelijst | active | nl | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.2.1--20171231000000 | TekstUitslagTypeCodelijst | active | nl | sct | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.6.1--20200901000000 | TelecomTypeCodelijst | active | nl | tho oid | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.6.1--20171231000000 | TelecomTypeCodelijst | active | nl | fhir oid | |||
signal.core.r4 | R4 | contact-point-system | ContactPointSystem | draft | 0 | fhir | 2019-10 | us | fhir |
nictiz.fhir.nl.r4.zib2020 | R4 | ContactInformation-TelephoneNumbersSystem | ContactPointSystem ValueSet for zib ContactInformation TelephoneNumbers | active | nl | fhir | |||
nhsd.assets.stu3 | R3 | EMS-ContactPointSystem-1 | ContactPointSystem | draft | 0 | fhir | 2017-04 | fhir | |
hl7.terminology | R5 | v3-LocalMarkupIgnore | LocalMarkupIgnore | active | 2014-03 | uv | tho | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.6.1--20200901000000 | TemperatuurTypeCodelijst | active | nl | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.6.1--20171231000000 | TemperatuurTypeCodelijst | active | nl | sct | |||
hl7.fhir.us.vitals | R4 | MeasurementProtocolVS | Measurement Protocol value set | draft | 2024-10 | us | fhir | ||
hl7.fhir.us.cardx-htn | R4 | MeasurementProtocolVS | Measurement Protocol value set | draft | 2023-08 | us | fhir | ||
hl7.terminology | R5 | v3-Loan | Loan | active | 2014-03 | uv | tho | ||
ee.fhir.terminology | R5 | teovoime-staatus | Teovõime staatus | active | 2025-06 | ee | internal | ||
openehr.base | R5 | term-binding-type | Term Binding Type ValueSet | informative | 3 | fhir | 2024-08 | uv | |
openehr.base | R5 | term-mapping-purpose | Term Mapping Purpose | informative | 3 | fhir | 2024-08 | uv | |
hl7.fhir.us.pco | R4 | goal-barrier-codes | Goal Barrier Assessment Codes | draft | 2 | pc | 2025-08 | us | sct |
hl7.fhir.us.pco | R4 | readiness-assessment-codes | Readiness Assessment Codes | draft | 2 | pc | 2025-08 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | spl-pharmaceutical-dosage-form-terminology | Pharmaceutical Dosage Form Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | spl-drug-route-of-administration-terminology | Drug Route Of Administration Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-name-part-terminology | PQCMC Name Part Terminology | trial-use | 2 | brr | 2025-07 | us | tho |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-batch-utilization-terminology | Batch utilization Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-chemical-structure-datafile-type-terminology | Chemical Structure Data File Type Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-closure-type-terminology | Closure Type Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-container-type-terminology | Container Type Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-drug-product-component-function-category-terminology | Drug Product Component Function Category Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-excipient-function-terminology | Excipient Function Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-impurity-classification-terminology | Impurity Classification Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-quality-benchmark-terminology | Quality Benchmark Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-source-type-terminology | Source Type Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-specification-status-terminology | Specification Status Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-specification-type-terminology | Specification Type Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-strength-type-terminology | Strength Type Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-test-category-terminology | Test Category Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-test-method-origin-terminology | Test Method Origin Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-test-usage-terminology | Test Usage Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-manufactured-dose-form-terminology | Manufactured Dose Form Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-units-of-measure | Units Of Measure | trial-use | 2 | brr | 2025-07 | us | ucum |
openehr.base | R5 | territories | Territories | informative | 3 | fhir | 2024-08 | uv | iso |
hl7.terminology | R5 | v3-tst0280 | _0280 | active | 2014-03 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.319 | Steward Transfer Test | active | 2024-07 | us | rx | ||
ca.on.oh-olis | R4 | olis-TestRequestCodes | TestRequestCodes | active | |||||
hl7.eu.fhir.idea4rc | R4 | simpleResult-eu-i4rc | Simple measures | active | 2025-07 | eu |